These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30944812)

  • 21. Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and Death.
    Jachs M; Hartl L; Simbrunner B; Bauer D; Paternostro R; Scheiner B; Schwabl P; Stättermayer AF; Pinter M; Eigenbauer E; Quehenberger P; Trauner M; Reiberger T; Mandorfer M
    Clin Gastroenterol Hepatol; 2022 Jun; 20(6):1362-1373.e6. PubMed ID: 34256145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spleen and liver stiffness for noninvasive assessment of portal hypertension in cirrhotic patients with large esophageal varices.
    Tseng Y; Li F; Wang J; Chen S; Jiang W; Shen X; Wu S
    J Clin Ultrasound; 2018 Sep; 46(7):442-449. PubMed ID: 30132919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virtual Hepatic Venous Pressure Gradient with CT Angiography (CHESS 1601): A Prospective Multicenter Study for the Noninvasive Diagnosis of Portal Hypertension.
    Qi X; An W; Liu F; Qi R; Wang L; Liu Y; Liu C; Xiang Y; Hui J; Liu Z; Qi X; Liu C; Peng B; Ding H; Yang Y; He X; Hou J; Tian J; Li Z
    Radiology; 2019 Feb; 290(2):370-377. PubMed ID: 30457484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Von-Willebrand factor as a predictor of three-month mortality in patients with liver cirrhosis compared to MELD score.
    Curakova Ristovska E; Genadieva-Dimitrova M; Caloska-Ivanova V; Misevski J
    Acta Gastroenterol Belg; 2019; 82(4):487-493. PubMed ID: 31950803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension.
    Mandorfer M; Kozbial K; Schwabl P; Freissmuth C; Schwarzer R; Stern R; Chromy D; Stättermayer AF; Reiberger T; Beinhardt S; Sieghart W; Trauner M; Hofer H; Ferlitsch A; Ferenci P; Peck-Radosavljevic M
    J Hepatol; 2016 Oct; 65(4):692-699. PubMed ID: 27242316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteopontin: A non-invasive parameter of portal hypertension and prognostic marker of cirrhosis.
    Bruha R; Jachymova M; Petrtyl J; Dvorak K; Lenicek M; Urbanek P; Svestka T; Vitek L
    World J Gastroenterol; 2016 Mar; 22(12):3441-50. PubMed ID: 27022226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CT perfusion imaging of the liver and the spleen in patients with cirrhosis: Is there a correlation between perfusion and portal venous hypertension?
    Talakić E; Schaffellner S; Kniepeiss D; Mueller H; Stauber R; Quehenberger F; Schoellnast H
    Eur Radiol; 2017 Oct; 27(10):4173-4180. PubMed ID: 28321540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis.
    Berzigotti A; Seijo S; Arena U; Abraldes JG; Vizzutti F; García-Pagán JC; Pinzani M; Bosch J
    Gastroenterology; 2013 Jan; 144(1):102-111.e1. PubMed ID: 23058320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TIMP-1 in patients with cirrhosis: relation to liver dysfunction, portal hypertension, and hemodynamic changes.
    Busk TM; Bendtsen F; Nielsen HJ; Jensen V; Brünner N; Møller S
    Scand J Gastroenterol; 2014 Sep; 49(9):1103-10. PubMed ID: 25048331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pro-C5, a marker of true type V collagen formation and fibrillation, correlates with portal hypertension in patients with alcoholic cirrhosis.
    Leeming DJ; Veidal SS; Karsdal MA; Nielsen MJ; Trebicka J; Busk T; Bendtsen F; Krag A; Møller S
    Scand J Gastroenterol; 2015 May; 50(5):584-92. PubMed ID: 25639675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrahepatic angiogenesis increases portal hypertension in hepatitis B patients with cirrhosis.
    Wang L; Zhao X; Feng Y; Ma X; Wu H; Zhu Q
    Hepatol Res; 2017 Mar; 47(3):E94-E103. PubMed ID: 27115574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patients With Signs of Advanced Liver Disease and Clinically Significant Portal Hypertension Do Not Necessarily Have Cirrhosis.
    Rodrigues SG; Montani M; Guixé-Muntet S; De Gottardi A; Berzigotti A; Bosch J
    Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2101-2109.e1. PubMed ID: 30625404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of Doppler ultrasound parameters of portal vein and hepatic artery in the diagnosis of cirrhosis and portal hypertension.
    Iwao T; Toyonaga A; Oho K; Tayama C; Masumoto H; Sakai T; Sato M; Tanikawa K
    Am J Gastroenterol; 1997 Jun; 92(6):1012-7. PubMed ID: 9177521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changing waveform during respiration on hepatic vein Doppler sonography of severe portal hypertension: comparison with the damping index.
    Kim SY; Jeong WK; Kim Y; Heo JN; Kim MY; Kim TY; Sohn JH
    J Ultrasound Med; 2011 Apr; 30(4):455-62. PubMed ID: 21460144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Supersonic shear imaging for the diagnosis of liver fibrosis and portal hypertension in liver diseases: a meta-analysis.
    Deng H; Qi X; Zhang T; Qi X; Yoshida EM; Guo X
    Expert Rev Gastroenterol Hepatol; 2018 Jan; 12(1):91-98. PubMed ID: 29186994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic vein arrival time as assessed by contrast-enhanced ultrasonography is useful for the assessment of portal hypertension in compensated cirrhosis.
    Kim MY; Suk KT; Baik SK; Kim HA; Kim YJ; Cha SH; Kwak HR; Cho MY; Park HJ; Jeon HK; Park SY; Kim BR; Hong JH; Jo KW; Kim JW; Kim HS; Kwon SO; Chang SJ; Baik GH; Kim DJ
    Hepatology; 2012 Sep; 56(3):1053-62. PubMed ID: 22473911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnostic accuracy of liver and spleen stiffness by two dimensional shear wave elastography for portal hypertension in hepatitis B-related cirrhosis].
    Zhu YL; Ding H; Fu TT; Xu ZT; Xue LY; Chen SY; Wang WP
    Zhonghua Yi Xue Za Zhi; 2020 Jun; 100(21):1654-1657. PubMed ID: 32486601
    [No Abstract]   [Full Text] [Related]  

  • 39. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis.
    Lemoine M; Katsahian S; Ziol M; Nahon P; Ganne-Carrie N; Kazemi F; Grando-Lemaire V; Trinchet JC; Beaugrand M
    Aliment Pharmacol Ther; 2008 Nov; 28(9):1102-10. PubMed ID: 18691352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Von Willebrand Factor as a Biomarker for Liver Disease - An Update.
    Elhence A; Shalimar
    J Clin Exp Hepatol; 2023; 13(6):1047-1060. PubMed ID: 37975050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.